Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A 6-mRNA host response whole-blood classifier trained using patients with non-COVID-19 viral infections accurately predicts severity of COVID-19

View ORCID ProfileLjubomir Buturovic, Hong Zheng, View ORCID ProfileBenjamin Tang, Kevin Lai, View ORCID ProfileWin Sen Kuan, View ORCID ProfileMark Gillett, Rahul Santram, Maryam Shojaei, View ORCID ProfileRaquel Almansa, Jose Ángel Nieto, Sonsoles Muñoz, Carmen Herrero, View ORCID ProfileNikolaos Antonakos, Panayiotis Koufargyris, Marina Kontogiorgi, View ORCID ProfileGeorgia Damoraki, Oliver Liesenfeld, James Wacker, Uros Midic, Roland Luethy, David Rawling, Melissa Remmel, Sabrina Coyle, Yiran Liu, Aditya M Rao, Denis Dermadi, Jiaying Toh, Lara Murphy Jones, Michele Donato, View ORCID ProfilePurvesh Khatri, View ORCID ProfileEvangelos J. Giamarellos-Bourboulis, Timothy E Sweeney
doi: https://doi.org/10.1101/2020.12.07.20230235
Ljubomir Buturovic
1Inflammatix, Inc., 863 Mitten Rd, Suite 104, Burlingame, CA, 94010, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ljubomir Buturovic
Hong Zheng
2Institute for Immunity, Transplantation and Infection, School of Medicine, Stanford University, Palo Alto, CA 94305, USA
3Center for Biomedical Informatics Research, Department of Medicine, Stanford University, Stanford, CA 94305, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Tang
4Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, Sydney, Australia
5Department of Intensive Care Medicine, Nepean Hospital, Sydney, Australia
6Nepean Genomic Research Group, Nepean Clinical School, University of Sydney, Sydney, Australia
7Marie Bashir Institute for Infectious Diseases and Biosecurity, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Benjamin Tang
Kevin Lai
8Department of Emergency Medicine, Westmead Hospital, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Win Sen Kuan
9Department of Emergency Medicine, National University Hospital Singapore, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Win Sen Kuan
Mark Gillett
10Department of Emergency Medicine, Royal North Shore Hospital, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mark Gillett
Rahul Santram
11Department of Emergency Medicine, St Vincent Hospital, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maryam Shojaei
4Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, Sydney, Australia
5Department of Intensive Care Medicine, Nepean Hospital, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raquel Almansa
12Group for Biomedical Research in Sepsis (BioSepsis), Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain & Hospital Universitario Río Hortega, Valladolid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Raquel Almansa
Jose Ángel Nieto
13Servicio de Urgencias de Atención Primaria, Salamanca
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sonsoles Muñoz
13Servicio de Urgencias de Atención Primaria, Salamanca
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carmen Herrero
13Servicio de Urgencias de Atención Primaria, Salamanca
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nikolaos Antonakos
144th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, 124 62 Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nikolaos Antonakos
Panayiotis Koufargyris
144th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, 124 62 Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marina Kontogiorgi
144th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, 124 62 Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georgia Damoraki
144th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, 124 62 Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Georgia Damoraki
Oliver Liesenfeld
1Inflammatix, Inc., 863 Mitten Rd, Suite 104, Burlingame, CA, 94010, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Wacker
1Inflammatix, Inc., 863 Mitten Rd, Suite 104, Burlingame, CA, 94010, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Uros Midic
1Inflammatix, Inc., 863 Mitten Rd, Suite 104, Burlingame, CA, 94010, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roland Luethy
1Inflammatix, Inc., 863 Mitten Rd, Suite 104, Burlingame, CA, 94010, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Rawling
1Inflammatix, Inc., 863 Mitten Rd, Suite 104, Burlingame, CA, 94010, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melissa Remmel
1Inflammatix, Inc., 863 Mitten Rd, Suite 104, Burlingame, CA, 94010, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabrina Coyle
1Inflammatix, Inc., 863 Mitten Rd, Suite 104, Burlingame, CA, 94010, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yiran Liu
2Institute for Immunity, Transplantation and Infection, School of Medicine, Stanford University, Palo Alto, CA 94305, USA
15Cancer Biology program, Stanford University, CA 94305
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aditya M Rao
2Institute for Immunity, Transplantation and Infection, School of Medicine, Stanford University, Palo Alto, CA 94305, USA
16Immunology program, Stanford University, CA 94305
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Denis Dermadi
2Institute for Immunity, Transplantation and Infection, School of Medicine, Stanford University, Palo Alto, CA 94305, USA
3Center for Biomedical Informatics Research, Department of Medicine, Stanford University, Stanford, CA 94305, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiaying Toh
2Institute for Immunity, Transplantation and Infection, School of Medicine, Stanford University, Palo Alto, CA 94305, USA
16Immunology program, Stanford University, CA 94305
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lara Murphy Jones
2Institute for Immunity, Transplantation and Infection, School of Medicine, Stanford University, Palo Alto, CA 94305, USA
17Division of Critical Care Medicine, Department of Pediatrics, School of Medicine, Stanford University, CA 94305
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michele Donato
2Institute for Immunity, Transplantation and Infection, School of Medicine, Stanford University, Palo Alto, CA 94305, USA
3Center for Biomedical Informatics Research, Department of Medicine, Stanford University, Stanford, CA 94305, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Purvesh Khatri
2Institute for Immunity, Transplantation and Infection, School of Medicine, Stanford University, Palo Alto, CA 94305, USA
3Center for Biomedical Informatics Research, Department of Medicine, Stanford University, Stanford, CA 94305, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Purvesh Khatri
Evangelos J. Giamarellos-Bourboulis
144th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, 124 62 Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Evangelos J. Giamarellos-Bourboulis
Timothy E Sweeney
1Inflammatix, Inc., 863 Mitten Rd, Suite 104, Burlingame, CA, 94010, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tsweeney{at}inflammatix.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background While major progress has been made to establish diagnostic tools for the identification of SARS-CoV-2 infection, determining the severity of COVID-19 remains an unmet medical need. There is a limited availability of hospital resources in this or any pandemic, and appropriately gauging severity would allow for some patients to safely recover in home quarantine, while ensuring that sicker patients get needed care.

Methods We here developed a blood-based generalizable host-gene-expression-based classifier for the severity of viral infections and validated it in multiple viral infection settings including COVID-19. We used training data (N=705) from 21 retrospective transcriptomic clinical studies of influenza and other viral illnesses looking at a preselected panel of host immune mRNAs.

Results We selected 6 host mRNAs and trained a logistic regression classifier with a training cross-validation AUROC of 0.90 for predicting 30-day mortality in viral illnesses. Next, in 1,417 samples across 21 independent retrospective validation cohorts the locked 6-mRNA classifier had an AUROC of 0.91 for discriminating patients with severe vs. non-severe infection. Next, in an independent cohort of prospectively enrolled patients with confirmed COVID-19 (N=97) in Athens, Greece, the 6-mRNA locked classifier had an AUROC of 0.89 for identifying patients with severe respiratory failure or 30-day mortality. Finally, we developed an isothermal qRT-LAMP (loop-mediated isothermal gene expression) assay for the 6-mRNA panel to facilitate implementation as a rapid assay.

Conclusions With further study, the classifier could assist in the risk assessment of patients with confirmed SARS-CoV-2 infection and COVID-19 to determine severity and level of care, thereby improving patient management and healthcare burden.

Competing Interest Statement

LB, OL, JW, UM, RL, DR, MR, SC, and TES are employees of, and stockholders in, Inflammatix, Inc, which is developing the 6-mRNA score into a commercial assay, CoVerityTM. PK is a shareholder and a consultant to Inflammatix, Inc. EJGB has received honoraria from AbbVie USA, Abbott CH, InflaRx GmbH, MSD Greece, XBiotech Inc. and Angelini Italy; independent educational grants from AbbVie, Abbott, Astellas Pharma Europe, AxisShield, bioMerieux Inc, InflaRx GmbH, and XBiotech Inc; and funding from the FrameWork 7 program HemoSpec (granted to the National and Kapodistrian University of Athens), the Horizon2020 Marie-Curie Project European Sepsis Academy (granted to the National and Kapodistrian University of Athens), and the Horizon 2020 European Grant ImmunoSep (granted to the Hellenic Institute for the Study of Sepsis). The other authors declare no competing interests.

Clinical Trial

EudraCT 2020-001039-29

Funding Statement

This study was funded by Inflammatix Inc. No external funding was received

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

COVID-19 blood samples were collected between March and April 2020. The studies were conducted following approvals for the collection of biomaterial for transcriptomic analysis for patients with lower respiratory tract infections provided by the Ethics Committees of the participating hospitals. The studies were conducted under the 23/12.08.2019 approval of the Ethics Committee of Sotiria Athens General Hospital; and the 26.02.2019 approval of the Ethics Committee of ATTIKON University General Hospital. Written informed consent was provided by patients or by first-degree relatives in case of patients unable to consent. For Australia/WIMR study, the written consent is provided by all patients or by first-degree relatives in case of patients unable to consent. The study was approved by the human research ethics committee of the Nepean Blue Mountains Area Health Services. For PREVISE study, the IRB was approved by COMITE DE ETICA DE LA INVESTIGACION CON MEDICAMENTOS DEL AREA DE SALUD DE SALAMANCA, Paseo de San Vicente, 58-18, 237007 Salamanca, Spain For healthy commercial controls, blood RNA tubes were prospectively collected from healthy controls (HC) through a commercial vendor (BioIVT) under IRB approval (Western IRB #2016165) using informed consent. Stanford ICU databank and PROMPT studies have previously been published and provided IRB details.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵* Co-first authors

  • ↵§ Co-senior authors

Data Availability

The public cohorts are available under their respective study IDs. The Stanford ICU Databank study is available at https://doi.org/10.1038/s41467-020-14975-w. The COVID-19 NanoString data are available upon reasonable request from the authors.

https://doi.org/10.1038/s41467-020-14975-w

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted December 08, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A 6-mRNA host response whole-blood classifier trained using patients with non-COVID-19 viral infections accurately predicts severity of COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A 6-mRNA host response whole-blood classifier trained using patients with non-COVID-19 viral infections accurately predicts severity of COVID-19
Ljubomir Buturovic, Hong Zheng, Benjamin Tang, Kevin Lai, Win Sen Kuan, Mark Gillett, Rahul Santram, Maryam Shojaei, Raquel Almansa, Jose Ángel Nieto, Sonsoles Muñoz, Carmen Herrero, Nikolaos Antonakos, Panayiotis Koufargyris, Marina Kontogiorgi, Georgia Damoraki, Oliver Liesenfeld, James Wacker, Uros Midic, Roland Luethy, David Rawling, Melissa Remmel, Sabrina Coyle, Yiran Liu, Aditya M Rao, Denis Dermadi, Jiaying Toh, Lara Murphy Jones, Michele Donato, Purvesh Khatri, Evangelos J. Giamarellos-Bourboulis, Timothy E Sweeney
medRxiv 2020.12.07.20230235; doi: https://doi.org/10.1101/2020.12.07.20230235
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A 6-mRNA host response whole-blood classifier trained using patients with non-COVID-19 viral infections accurately predicts severity of COVID-19
Ljubomir Buturovic, Hong Zheng, Benjamin Tang, Kevin Lai, Win Sen Kuan, Mark Gillett, Rahul Santram, Maryam Shojaei, Raquel Almansa, Jose Ángel Nieto, Sonsoles Muñoz, Carmen Herrero, Nikolaos Antonakos, Panayiotis Koufargyris, Marina Kontogiorgi, Georgia Damoraki, Oliver Liesenfeld, James Wacker, Uros Midic, Roland Luethy, David Rawling, Melissa Remmel, Sabrina Coyle, Yiran Liu, Aditya M Rao, Denis Dermadi, Jiaying Toh, Lara Murphy Jones, Michele Donato, Purvesh Khatri, Evangelos J. Giamarellos-Bourboulis, Timothy E Sweeney
medRxiv 2020.12.07.20230235; doi: https://doi.org/10.1101/2020.12.07.20230235

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3298)
  • Dentistry and Oral Medicine (365)
  • Dermatology (280)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1173)
  • Epidemiology (13384)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5157)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3274)
  • Health Policy (1143)
  • Health Systems and Quality Improvement (1193)
  • Hematology (432)
  • HIV/AIDS (1019)
  • Infectious Diseases (except HIV/AIDS) (14636)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (478)
  • Medical Ethics (127)
  • Nephrology (525)
  • Neurology (4930)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (886)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (727)
  • Orthopedics (282)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (544)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4218)
  • Public and Global Health (7512)
  • Radiology and Imaging (1708)
  • Rehabilitation Medicine and Physical Therapy (1016)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (498)
  • Sports Medicine (424)
  • Surgery (549)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)